Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility

Molecular and Cellular Biology

Volumn 33, Issue 8, 2013, Pages 1657-1670

  Zhang, Xiaocui ^a   Lavoie, Genevieve ^a   Fort, Loic ^a   Huttlin, Edward L ^b   Tcherkezian, Joseph ^a   Galan, Jacob A ^a   Gu, Haihua ^c   Gygi, Steven P ^b   Carreno, Sebastien ^a,d   Roux, Philippe P ^a,d  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN GRB2 ASSOCIATED BINDER; PROTEIN P90; PROTEIN S6; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CELL SELECTION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BENZAMIDES; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; FEMALE; GRB2 ADAPTOR PROTEIN; HEK293 CELLS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84876320925     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01353-12     Document Type: Article

References (43)

1. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134.
2. Murphy LO, Blenis J. 2006. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31:268-275.
3. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320-344.
4. Cargnello M, Roux PP. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75:50-83.
5. Romeo Y, Zhang X, Roux PP. 2012. Regulation and function of the RSK family of protein kinases. Biochem. J. 441:553-569.
6. Carriere A, Ray H, Blenis J, Roux PP. 2008. The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 13:4258-4275.
7. Brummer T, Schmitz-Peiffer C, Daly RJ. 2010. Docking proteins. FEBS J. 277:4356-4369.
8. Gu H, Neel BG. 2003. The "Gab" in signal transduction. Trends Cell Biol. 13:122-130.
9. Wohrle FU, Daly RJ, Brummer T. 2009. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun. Signal 7:22. doi:10.1186/1478-811X-7-22.
10. Wohrle FU, Daly RJ, Brummer T. 2009. How to Grb2 a Gab. Structure 17:779-781.
11. Nishida K, Hirano T. 2003. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci. 94:1029-1033.
12. Celebi JT, Adams SJ, Aydin IT. 2012. GAB2-a scaffolding protein in cancer. Mol. Cancer Res. 10:1265-1270.
13. Brummer T, Schramek D, Hayes VM, Bennett HL, Caldon CE, Musgrove EA, Daly RJ. 2006. Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. J. Biol. Chem. 281:626-637.
14. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, Harris LN, Richardson A, Neel BG, Gu H. 2006. A role for the scaffolding adapter GAB2 in breast cancer. Nat. Med. 12:114-121.
15. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerod A, Han W, Noh DY, Jeffrey SS, Huntsman DG, Borresen-Dale AL, Pollack JR. 2010. Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene 29:774-779.
16. Herrera Abreu MT, Hughes WE, Mele K, Lyons RJ, Rickwood D, Browne BC, Bennett HL, Vallotton P, Brummer T, Daly RJ. 2011. Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation. Mol. Biol. Cell 22:105-116.
17. Lynch DK, Daly RJ. 2002. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21:72-82.
18. Arnaud M, Crouin C, Deon C, Loyaux D, Bertoglio J. 2004. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. J. Immunol. 173:3962-3971.
19. Brummer T, Larance M, Herrera Abreu MT, Lyons RJ, Timpson P, Emmerich CH, Fleuren ED, Lehrbach GM, Schramek D, Guilhaus M, James DE, Daly RJ. 2008. Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J. 27:2305-2316.
20. Caron C, Spring K, Laramee M, Chabot C, Cloutier M, Gu H, Royal I. 2009. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells. Cell Signal. 21:943-953.
21. Lock LS, Maroun CR, Naujokas MA, Park M. 2002. Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis. Mol. Biol. Cell 13:2132-2146.
22. Romeo Y, Moreau J, Zindy PJ, Saba-El-Leil M, Lavoie G, Dandachi F, Baptissart M, Borden KL, Meloche S, Roux PP. 16 July 2012. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth. Oncogene {left open bracket}Epub ahead of print.{right open bracket} doi:10.1038/onc.2012.312.
23. Carriere A, Romeo Y, Acosta-Jaquez HA, Moreau J, Bonneil E, Thibault P, Fingar DC, Roux PP. 2011. ERK1/2 phosphorylate Raptor to promote Ras-dependent activation ofmTORcomplex 1 (mTORC1). J. Biol. Chem. 286:567-577.
24. Carriere A, Cargnello M, Julien LA, Gao H, Bonneil E, Thibault P, Roux PP. 2008. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr. Biol. 18:1269-1277.
25. Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG. 2001. Essential role for Gab2 in the allergic response. Nature 412:186-190.
26. Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J. 2004. Tumorpromoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U. S. A. 101:13489-13494.
27. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
28. Cargnello M, Tcherkezian J, Dorn JF, Huttlin EL, Maddox PS, Gygi SP, Roux PP. 2012. 4E-T phosphorylation by JNK promotes stress-dependent P-body assembly. Mol. Cell. Biol. 32:4572-4584.
29. Ting L, Rad R, Gygi SP, Haas W. 2011. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat. Methods 8:937-940.
30. Rappsilber J, Ishihama Y, Mann M. 2003. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75:663-670.
31. Yates JR, III, Eng JK, McCormack AL, Schieltz D. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67:1426-1436.
32. Elias JE, Gygi SP. 2007. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4:207-214.
33. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villen J, Haas W, Sowa ME, Gygi SP. 2010. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143: 1174-1189.
34. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP. 2006. A probabilitybased approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24:1285-1292.
35. Hochberg Y, Benjamini Y. 1990. More powerful procedures for multiple significance testing. Stat. Med. 9:811-818.
36. Julien LA, Carriere A, Moreau J, Roux PP. 2010. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30:908-921.
37. Alessi DR, Caudwell FB, Andjelkovic M, Hemmings BA, Cohen P. 1996. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:333-338.
38. Huang F, Tong X, Deng H, Fu L, Zhang R. 2008. Inhibition of the antigen-induced activation of RBL-2H3 cells by Gab2 siRNA. Cell. Mol. Immunol. 5:433-438.
39. Saha M, Carriere A, Cheerathodi M, Zhang X, Lavoie G, Rush J, Roux PP, Ballif BA. 2012. RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation. Biochem. J. 447:159-166.
40. Neel BG, Gu H, Pao L. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284-293.
41. Lee HH, Chang ZF. 2008. Regulation of RhoA-dependent ROCKII activation by Shp2. J. Cell Biol. 181:999-1012.
42. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G, Blenis J. 2011. ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol. Cell 41:661-671.
43. Romeo Y, Roux PP. 2011. Paving the way for targeting RSK in cancer. Expert Opin. Ther. Targets 15:5-9.